GBS insider filings
GBS Inc. — 48 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-10-12. Screen GBS transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for GBS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — GBS Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-10-12 | 4 | Simeonidis Harry — President | Grant/award (A): 80,000 @ $0 | EDGAR |
| 2022-10-12 | 4 | Hurd Jonathan Scott — Director | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2022-10-12 | 4 | TOWERS CHRISTOPHER — Director | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2022-10-12 | 4 | Margelis George — Director | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2022-10-12 | 4 | Boyages Steven Constantine — Interim CEO and Chairperson, Director | Grant/award (A): 75,000 @ $0 | EDGAR |
| 2022-10-12 | 4 | Sakiris Spiro Kevin — Chief Financial Officer | Grant/award (A): 75,000 @ $0 | EDGAR |
| 2022-10-12 | 4 | FISHER LAWRENCE B — Director | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2022-06-24 | 4 | Sakiris Spiro Kevin — Chief Financial Officer | Purchase (P): 5,000 @ $0.65 | EDGAR |
| 2022-06-22 | 4 | Sakiris Spiro Kevin — ChiefFinancial Officer | Purchase (P): 15,970 @ $0.61 | EDGAR |
| 2022-02-22 | 4 | Life Science Biosensor Diagnostics Pty Ltd | Sale (S): 576,028 @ $0.51 | EDGAR |
| 2022-02-18 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $0.63 | EDGAR |
| 2022-02-17 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $0.75 · Sale (S): 100,000 @ $0.70 · Sale (S): 100,000 @ $0.68 | EDGAR |
| 2022-02-15 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $0.84 | EDGAR |
| 2022-02-11 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $0.86 | EDGAR |
| 2022-02-10 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $0.89 | EDGAR |
| 2022-02-08 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $0.92 | EDGAR |
| 2022-02-03 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $0.90 | EDGAR |
| 2022-02-01 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $0.92 | EDGAR |
| 2022-02-01 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $1 | EDGAR |
| 2022-01-03 | 4 | Parmakellis Tom — Director | Purchase (P): 4,500 @ $1.55 | EDGAR |
| 2021-12-21 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 200,000 @ $1.49 | EDGAR |
| 2021-12-20 | 4 | Parmakellis Tom — Director | Purchase (P): 2,800 @ $1.69 | EDGAR |
| 2021-12-07 | 4 | Sakiris Spiro Kevin — ChiefFinancial Officer | Purchase (P): 10,000 @ $1.70 | EDGAR |
| 2021-12-03 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 250,000 @ $1.87 | EDGAR |
| 2021-12-01 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $1.69 | EDGAR |
| 2021-11-29 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $1.64 | EDGAR |
| 2021-11-12 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 300,000 @ $2.02 | EDGAR |
| 2021-10-25 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 248,416 @ $2.26 | EDGAR |
| 2021-10-22 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 24,209 @ $2.25 | EDGAR |
| 2021-10-21 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 16,326 @ $2.25 | EDGAR |
| 2021-10-18 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,726 @ $2.18 | EDGAR |
| 2021-10-15 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 58,739 @ $2.25 | EDGAR |
| 2021-10-14 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $2.13 | EDGAR |
| 2021-10-12 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 200,000 @ $2.30 | EDGAR |
| 2021-09-30 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 200,000 @ $2.48 | EDGAR |
| 2021-09-30 | 4 | Parmakellis Tom — Director | Purchase (P): 1,000 @ $2.40 | EDGAR |
| 2021-09-28 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 200,000 @ $2.66 | EDGAR |
| 2021-09-27 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $2.77 | EDGAR |
| 2021-09-24 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $2.80 | EDGAR |
| 2021-09-23 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $2.83 | EDGAR |
| 2021-09-22 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 100,000 @ $2.90 | EDGAR |
| 2021-09-22 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Sale (S): 45,152 @ $3.29 | EDGAR |
| 2021-06-28 | 4 | Parmakellis Tom — Director | Purchase (P): 1,000 @ $4.44 | EDGAR |
| 2021-05-21 | 4 | Sakiris Spiro Kevin — Chief Financial Officer | Purchase (P): 10,000 @ $3.07 | EDGAR |
| 2021-03-03 | 4 | Gavrilenko Victoria — Director | Purchase (P): 36.63 @ $8.09 | EDGAR |
| 2021-02-25 | 4 | TOWERS CHRISTOPHER — Director | Purchase (P): 800 @ $6.84 | EDGAR |
| 2021-02-16 | 4 | Sakiris Spiro Kevin — Chief Financial Officer | Option exercise/expiry (X): 1,479 · Option exercise/expiry (X): 1,479 (derivative) | EDGAR |
| 2021-01-21 | 4 | Life Science Biosensor Diagnostics Pty Ltd — 10% owner | Option exercise/expiry (X): 117,647 · Option exercise/expiry (X): 117,647 (derivative) | EDGAR |
Recent 8-K events — GBS Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-13 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-11 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-09 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-01 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GBS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs